At the upcoming Society of Nuclear Medicine Meeting (SNM) in Salt Lake City, UT June 5th-9th Positron
Corporation, a molecular imaging solutions company focused on Nuclear Cardiology, will exhibit to promote their cardiac optimized PET scanner, the Attrius™.
Cardiac PET has seen a novel rise in demand as doctors and hospitals look toward modalities that offer better medicine to their patients while lowering operational costs although there has been continued uncertainty of the worlds Molybdenum supply and recent increase in PET reimbursement & decrease in SPECT reimbursement. "The demand for Cardiovascular PET imaging is rapidly increasing as it enables the physician to provide better patient care through a more accurate diagnosis, the potential to reduce unnecessary downstream procedures and limit radiation exposure." Joseph Oliverio, Chief Technology Officer, states. "The Attrius™ has a small footprint, robust standard cardiovascular software package, competitive scan times and an affordable cost of entry making the Attrius™ the right choice for enhancing the capabilities of a Cardiovascular practices."